[go: up one dir, main page]

AR004476A1 - Compuestos biciclicos, su preparacion y su utilizacion en composiciones farmaceuticas - Google Patents

Compuestos biciclicos, su preparacion y su utilizacion en composiciones farmaceuticas

Info

Publication number
AR004476A1
AR004476A1 ARP960101616A AR10161696A AR004476A1 AR 004476 A1 AR004476 A1 AR 004476A1 AR P960101616 A ARP960101616 A AR P960101616A AR 10161696 A AR10161696 A AR 10161696A AR 004476 A1 AR004476 A1 AR 004476A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
preparation
bicycle compounds
compounds
bicycle
Prior art date
Application number
ARP960101616A
Other languages
English (en)
Original Assignee
Menarini Farma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11351134&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR004476(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Menarini Farma Ind filed Critical Menarini Farma Ind
Publication of AR004476A1 publication Critical patent/AR004476A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

La presente invención se refiere a novedosos compuestos que responden a la siguiente fórmula general (I) y también se refiere a composicionesfarmacéuticas que los contienen.
ARP960101616A 1995-03-13 1996-03-01 Compuestos biciclicos, su preparacion y su utilizacion en composiciones farmaceuticas AR004476A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95FI000044A IT1277835B1 (it) 1995-03-13 1995-03-13 Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche

Publications (1)

Publication Number Publication Date
AR004476A1 true AR004476A1 (es) 1998-12-16

Family

ID=11351134

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960101616A AR004476A1 (es) 1995-03-13 1996-03-01 Compuestos biciclicos, su preparacion y su utilizacion en composiciones farmaceuticas

Country Status (33)

Country Link
US (1) US6150325A (es)
EP (1) EP0815126B1 (es)
JP (1) JP4618821B2 (es)
KR (1) KR100405009B1 (es)
CN (1) CN1189477C (es)
AR (1) AR004476A1 (es)
AT (1) ATE198481T1 (es)
AU (1) AU696528B2 (es)
BG (1) BG63208B1 (es)
BR (1) BR9607348A (es)
CZ (1) CZ287372B6 (es)
DE (1) DE69611438T2 (es)
DK (1) DK0815126T3 (es)
EA (1) EA000697B1 (es)
EE (1) EE03618B1 (es)
ES (1) ES2155187T3 (es)
GE (1) GEP20002271B (es)
GR (1) GR3035676T3 (es)
HR (1) HRP960117B1 (es)
HU (1) HU222051B1 (es)
IL (1) IL117395A (es)
IT (1) IT1277835B1 (es)
MX (1) MX9706927A (es)
NO (1) NO319290B1 (es)
NZ (1) NZ303982A (es)
PL (1) PL184147B1 (es)
PT (1) PT815126E (es)
RO (1) RO118297B1 (es)
SK (1) SK281899B6 (es)
TW (1) TW565572B (es)
UA (1) UA48962C2 (es)
WO (1) WO1996028467A1 (es)
ZA (1) ZA961983B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017705A (en) * 1995-03-14 2000-01-25 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which are members of the MAGE-B family and uses thereof
IT1291776B1 (it) * 1997-02-07 1999-01-21 Menarini Ricerche Spa Composti monociclici a quattro residui bifunzionali, aventi azione nk-2 antagonista
IT1304888B1 (it) * 1998-08-05 2001-04-05 Menarini Ricerche Spa Composti monociclici ad azione nk-2 antagonista e formulazioni che licontengono
CA2412355A1 (en) * 2000-06-12 2001-12-20 University Of Rochester Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist
EP1297826A1 (en) * 2001-09-27 2003-04-02 Menarini Ricerche S.p.A. Nasal pharmaceutical compositions containing a NK-2 antagonist
ITFI20020239A1 (it) * 2002-12-06 2004-06-07 Menarini Ricerche Spa Processo per la preparazione di composti peptidici biciclici.
ITFI20040221A1 (it) * 2004-10-27 2005-01-27 Guidotti & C Spa Composizioni farmaceutiche a base di nk2 antagonisti per uso pediatrico
ITRM20120331A1 (it) 2012-07-12 2014-01-13 Guidotti & C Spa Labor Composizioni pediatriche orali liquide contenenti nepadutant.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1262902B (it) * 1992-04-15 1996-07-22 Menarini Farma Ind Composti triciclici antagonisti delle tachichinine, loro preparazione e loro uso in composizioni farmaceutiche.

Also Published As

Publication number Publication date
NO974057D0 (no) 1997-09-03
KR100405009B1 (ko) 2004-05-20
BR9607348A (pt) 1997-12-30
GEP20002271B (en) 2000-10-25
CN1189477C (zh) 2005-02-16
RO118297B1 (ro) 2003-04-30
KR19980703011A (ko) 1998-09-05
MX9706927A (es) 1997-11-29
HUP9801835A3 (en) 2000-05-29
NO974057L (no) 1997-11-07
UA48962C2 (uk) 2002-09-16
DK0815126T3 (da) 2001-05-07
EP0815126B1 (en) 2001-01-03
EE9700230A (et) 1998-04-15
IL117395A (en) 1999-12-31
ES2155187T3 (es) 2001-05-01
HUP9801835A2 (hu) 1999-01-28
IT1277835B1 (it) 1997-11-12
EP0815126A1 (en) 1998-01-07
NZ303982A (en) 1998-04-27
WO1996028467A1 (en) 1996-09-19
DE69611438T2 (de) 2001-06-13
US6150325A (en) 2000-11-21
JPH11501643A (ja) 1999-02-09
HRP960117A2 (en) 1997-08-31
AU5105996A (en) 1996-10-02
ITFI950044A0 (it) 1995-03-13
BG101849A (en) 1998-04-30
HRP960117B1 (en) 2001-06-30
DE69611438D1 (de) 2001-02-08
CZ286297A3 (cs) 1998-02-18
EA199700223A1 (ru) 1998-04-30
EA000697B1 (ru) 2000-02-28
BG63208B1 (bg) 2001-06-29
HU222051B1 (hu) 2003-04-28
PL322105A1 (en) 1998-01-05
PL184147B1 (pl) 2002-09-30
ITFI950044A1 (it) 1996-09-13
JP4618821B2 (ja) 2011-01-26
SK121297A3 (en) 1998-02-04
SK281899B6 (sk) 2001-09-11
PT815126E (pt) 2001-06-29
NO319290B1 (no) 2005-07-11
GR3035676T3 (en) 2001-06-29
CZ287372B6 (en) 2000-11-15
AU696528B2 (en) 1998-09-10
TW565572B (en) 2003-12-11
ATE198481T1 (de) 2001-01-15
ZA961983B (en) 1997-09-29
CN1183786A (zh) 1998-06-03
IL117395A0 (en) 1996-07-23
EE03618B1 (et) 2002-02-15

Similar Documents

Publication Publication Date Title
MX9304581A (es) Desoxitaxoles y composiciones farmaceuticas que los contienen
AR001440A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
AR027162A1 (es) Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen
ATE198143T1 (de) Zahnpasten
TR199901305T2 (xx) Calpain-�nleyicileri olarak ketonbenzamidler
HN1997000118A (es) 1,3, oxa thiolane nucleoside compuestos y composiciones
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE69216532D1 (de) Azidfreie gaserzeugende Zusammensetzungen
MX9300498A (es) Derivados de n-sulfonil-2-oxo-indol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
PT747050E (pt) Composicoes farmaceuticas que contem irbesartan
CY2005007I1 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
EP0695171A1 (en) GONADOTROPINE CONTAINING FREEZER DRIED DROPS
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
MX9101399A (es) Composiciones que contienen psyllium
ES2091310T3 (es) Nuevos derivados de la n-benzoil-prolina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
AR002017A1 (es) Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento.
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
BG101401A (bg) Състави за орално приложение с удължено освобождаване на цисаприд
AR004476A1 (es) Compuestos biciclicos, su preparacion y su utilizacion en composiciones farmaceuticas
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
ES2160308T3 (es) Nuevos derivados amino-metil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2111871T3 (es) Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
MX9300840A (es) Compuestos farmaceuticos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
BR9806193A (pt) Composição bi-aromáticos ligados por um radical heteroetinileno e composições farmacêuticas e cosméticas que os contêm

Legal Events

Date Code Title Description
FG Grant, registration